LifeVoxel Selected as Top 20 Finalist for Prestigious Plug and Play Medtech Accelerator Program

We are thrilled to announce that LifeVoxel has been selected as one of the Top 20 startups invited to participate in the Selection Day for Plug and Play's Medtech Batch 3 program. This prestigious opportunity takes place in Warsaw, Indiana – widely recognized as the orthopedics capital of the world. Being chosen from among hundreds of innovative medtech companies represents a significant milestone in our journey to transform medical imaging with our AI-enabled radiology platform.

About the Selection

The rigorous selection process evaluated startups based on their innovative technology, market potential, and relevance to the orthopedics and musculoskeletal space. LifeVoxel will pitch our GPU-cloud based platform at Selection Day on March 6, 2025, at Zimmer Biomet's global headquarters. This opportunity places us among an elite group of medtech innovators competing for spots in the 3-month intensive acceleration program.

About Plug and Play Tech Center

Plug and Play Tech Center is one of the world's leading innovation platforms, connecting startups with established corporations across various industries. Their accelerator programs have helped launch and scale thousands of startups worldwide, with many going on to become industry leaders. The Medtech program specifically focuses on breakthrough healthcare technologies with the potential to revolutionize patient care in collaboration with industry giants.

The Program Opportunity

If selected as a final participant, LifeVoxel will join a 3-month intensive program working directly with major orthopedic industry leaders including Zimmer Biomet, OrthoPediatrics, Paragon Medical, and other key players in the space. The program offers unparalleled access to corporate executives, potential pilot opportunities, and strategic partnerships that could significantly accelerate our growth trajectory and market penetration.

LifeVoxel's Solution

Our AI-enabled radiology platform represents a paradigm shift from "Software as a Service" to "Service as a Software." This evolution means rather than simply providing software tools, we're delivering complete workflow solutions where the technology seamlessly integrates into and enhances medical services. The software becomes an active participant in healthcare delivery rather than just a tool—automating workflows, providing AI-driven insights, and creating value beyond traditional software functionality.

Our award-winning technology was crowned "Best of Radiology" at "The Minnies" in November 2023 and empowers radiologists, clinicians, and surgeons with advanced visualization tools and data-driven insights.

The platform's specific applications in orthopedic centers, spine surgery, and trauma centers make it particularly relevant to the Plug and Play Medtech program's focus. Our GPU-cloud based architecture enables instant diagnostic viewing on any device with zero latency, facilitating better surgical planning and clinical outcomes in orthopedic applications.

Looking Forward

"Being recognized by Plug and Play as a Top 20 medtech innovator validates our mission to revolutionize medical imaging through advanced AI and GPU-cloud technologies," says Kovey Kovalan, Founder and CEO of LifeVoxel. "We're excited about the opportunity to collaborate with industry leaders in orthopedics and further develop solutions that enhance patient care while improving operational efficiency."

The selection represents not only recognition of our technology's potential but also opens doors to strategic partnerships within the orthopedic ecosystem that could accelerate adoption and integration into clinical workflows.

Next Steps

Our team is now preparing for Selection Day on March 6th, where we'll showcase how our technology addresses critical challenges in orthopedic imaging and clinical workflows. The selection committee will evaluate all 20 finalists to determine which startups will advance to the full 3-month program.

Stay tuned for updates on our progress through this exciting opportunity. We look forward to sharing more news as we continue our mission to transform healthcare through advanced AI and visualization technologies.